Table 5. Association between characteristics and MPE response after 1st cycle of DEB-BACE therapy in DEB-BACE group.
| Items | No. | CR | PR or failure | P value |
|---|---|---|---|---|
| Age, No. (%) | 0.858 | |||
| <60 years | 8 | 5 (62.5) | 3 (37.5) | |
| ≥60 years | 9 | 6 (66.7) | 3 (33.3) | |
| Gender, No. (%) | 0.402 | |||
| Male | 9 | 5 (55.6) | 4 (44.4) | |
| Female | 8 | 6 (75.0) | 2 (25.0) | |
| History of smoke, No. (%) | 0.858 | |||
| Yes | 8 | 5 (62.5) | 3 (37.5) | |
| No | 9 | 6 (66.7) | 3 (33.3) | |
| ECOG score, No. (%) | 0.793 | |||
| <2 | 12 | 8 (66.7) | 4 (33.3) | |
| ≥2 | 5 | 3 (60.0) | 2 (40.0) | |
| Histological type, No. (%) | 0.349 | |||
| Adenocarcinoma | 11 | 8 (72.7) | 3 (27.3) | |
| Squamous carcinoma | 6 | 3 (50.0) | 3 (50.0) | |
Comparison was determined by Chi-square test. MPE, malignant pleural effusion; DEB-BACE, drug-eluting beads bronchial arterial chemoembolization; CR, complete remission; PR, partial remission; ECOG, Eastern Cooperative Oncology Group.